Literature DB >> 9421205

Alternatives to estrogen for menopausal women.

B Kessel1.   

Abstract

Limited acceptable alternatives to hormone replacement therapy exist for use by postmenopausal women. This oversight within the biomedical community is of particular concern considering the increasing number of postmenopausal women and the current low use of hormone replacement therapy. In addition, contraindications to hormone replacement therapy and controversies regarding recommendations for use of hormone replacement therapy also exist. With the notable exception of the advances in prevention of osteoporosis, alternatives to estrogen for other aspects of the sequelae of hypoestrogenism or aging are limited. Furthermore, there is widespread use of complementary therapies among postmenopausal women despite a lack of data on efficacy or safety of such therapies. Increased research into alternatives to estrogen for menopausal women is of clinical, scientific, and health policy importance.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9421205     DOI: 10.3181/00379727-217-44203

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  4 in total

Review 1.  Clinical practice guidelines for the care and treatment of breast cancer: 14. The role of hormone replacement therapy in women with a previous diagnosis of breast cancer.

Authors:  Kathleen I Pritchard; Humaira Khan; Mark Levine
Journal:  CMAJ       Date:  2002-04-16       Impact factor: 8.262

Review 2.  Chemoprevention of breast cancer: implications for postmenopausal women.

Authors:  Carol J Fabian; Bruce F Kimler
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

Review 3.  Dietary Management of Skin Health: The Role of Genistein.

Authors:  Natasha Irrera; Gabriele Pizzino; Rosario D'Anna; Mario Vaccaro; Vincenzo Arcoraci; Francesco Squadrito; Domenica Altavilla; Alessandra Bitto
Journal:  Nutrients       Date:  2017-06-17       Impact factor: 5.717

Review 4.  Can genistein be a potential agent against skin side effects associated with the treatment of breast cancer?

Authors:  Magda A Pawlicka; Agata Filip
Journal:  Postepy Dermatol Alergol       Date:  2022-02-28       Impact factor: 1.837

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.